Amanote Research
Register
Sign In
Cytosolic PKM2 Stabilizes Mutant EGFR Protein Expression Through Regulating HSP90-EGFR Association
Oncogene
- United Kingdom
doi 10.1038/onc.2017.18
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Genetics
Molecular Biology
Date
March 20, 2017
Authors
Y-C Yang
T-Y Cheng
S-M Huang
C-Y Su
P-W Yang
J-M Lee
C-K Chen
M Hsiao
K-T Hua
M-L Kuo
Publisher
Springer Science and Business Media LLC
Related search
Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Inhibition of Hsp90 Down-Regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel
Cancer Research
Cancer Research
Oncology
CD317 Activates EGFR by Regulating Its Association With Lipid Rafts
Cancer Research
Cancer Research
Oncology
Urea Cycle Sustains Cellular Energetics Upon EGFR Inhibition in EGFR Mutant NSCLC
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Immunohistochemical Expression of IDH1R132H in Astrocytictumours and Its Association With Histopathological Grade, TP53 and EGFR Protein Expression
Annals of Pathology and Laboratory Medicine
P2.13-21 MET Addiction Can Be Circumvented Through EGFR Inhibition via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression
Madridge Journal of Oncogenesis
Author Correction: Targeting Hsp90 With FS-108 Circumvents Gefitinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells
Acta Pharmacologica Sinica
Medicine
Pharmacology
Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
Expert Review of Anticancer Therapy
Oncology
Pharmacology
